Dr. Sai Pingali is board certified by the American Board of Internal Medicine in medical oncology and hematology.
Patients facing a relapse of diffuse large B-cell lymphoma often encounter complex choices about their next steps in treatment.
Here, Dr. Sai Pingali helps outline the key considerations for relapsed disease. Dr. Pingali is a board-certified medical oncologist and hematologist at Houston Methodist Oncology Partners, specializing in hematologic malignancies and stem cell transplantation, with a focus on advancing treatment options for patients who may be candidates for cellular therapies such as CAR T-cell therapy.
Dr. Sai Pingali
Houston Methodist
Lymphoma can progress rapidly, Dr. Sai Pingali tells SurvivorNet, so it's important to get eligible patients for CAR T-cell therapy into treatment quickly — but the process from diagnosis to treatment requires several steps.
Sign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.
